Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Posaconazole vs Itraconazole for IFD Prevention in HSCT
NCT03631602Phase 3Unknown
- Sponsor
- Fujian Medical University
- Start
- Oct 2017
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of posaconazole in invasive fungal disease (IFD), sponsored by Fujian Medical University. Primary endpoint: Incidence of breakthrough Invasive Fungal Disease at 1 year. Status: unknown.
02
Drugs
posaconazole
03
Conditions
invasive fungal disease (IFD)
Beyond the preview
Go deeper on NCT03631602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03631602.